Background: The most recent (2012) worldwide estimates from International Agency for Research on Cancer indicate that approximately 528,000 new cases and 270,000 deaths per year are attributed to cervical cancer worldwide. The disease is preventable with HPV vaccination and with early detection and treatment of pre-invasive cervical intraepithelial neoplasia, CIN. Antibodies (Abs) to HPV proteins are under investigation as potential biomarkers for early detection.
Download count: 0
- Digital object identifier: 10.7150/thno.21098
- Identifier TypeInternational standard serial numberIdentifier Value1309-1042
Citation and reuse
Cite this item
This is a suggested citation. Consult the appropriate style guide for specific citation guidelines.
Ewaisha, R., Panicker, G., Maranian, P., Unger, E. R., & Anderson, K. S. (2017). Serum Immune Profiling for Early Detection of Cervical Disease. Theranostics, 7(16), 3814-3823. doi:10.7150/thno.21098